Published in Endocrinology on February 01, 1977
Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci (1982) 3.02
Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol (1993) 1.92
Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist. Life Sci (1986) 1.80
Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol (1990) 1.26
Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology (1968) 1.24
The activity of peptides of the endothelin family in various mammalian smooth muscle preparations. Eur J Pharmacol (1989) 1.24
In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther (1991) 1.24
VAMPIRE: Vessel assessment and measurement platform for images of the REtina. Conf Proc IEEE Eng Med Biol Soc (2011) 1.21
The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Eur J Pharmacol (1989) 1.17
Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci U S A (1977) 1.16
A potent and selective agonist for NK-2 tachykinin receptor. Peptides (1989) 1.14
Adrenal-mediated endogenous metabolites inhibit puberty in female mice. Science (1986) 1.14
The effects of acute stress on the secretion of LH, FSH, prolactin and GH in the normal male rat, with comments on their statistical evaluation. Neuroendocrinology (1974) 1.13
New arylpyrido-diazepine and -thiodiazepine derivatives are potent and highly selective HIV-1 inhibitors targeted at the reverse transcriptase. Antiviral Res (1996) 1.09
Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther (1988) 1.03
Studies in vitro of amine uptake mechanisms in heart. Biochem Pharmacol (1966) 1.03
Evaluation and characterization of the hyt/hyt hypothyroid mouse. II. Abnormalities of TSH and the thyroid gland. Neuroendocrinology (1989) 1.00
AF-DX 116, a cardioselective muscarinic antagonist. J Pharmacol Exp Ther (1987) 1.00
A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan. Eur J Pharmacol (1990) 0.99
Simultaneous recording of vesical and urethral pressure in urethane-anesthetized rats: effect of neuromuscular blocking agents on the activity of the external urethral sphincter. J Pharmacol Methods (1991) 0.98
Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br J Pharmacol (1986) 0.98
Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev (1995) 0.97
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors. J Auton Pharmacol (1991) 0.97
(Imidazolylphenyl)formamidines. A structurally novel class of potent histamine H2 receptor antagonists. J Med Chem (1984) 0.97
Further evidence for the existence of NK2 tachykinin receptor subtypes. Br J Pharmacol (1991) 0.96
In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist. Eur J Pharmacol (1993) 0.96
Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Br J Pharmacol (1994) 0.96
Effects of hypothalamic and preoptic electrochemical stimulation on gonadotropin and prolactin release in proestrous rats. Endocrinology (1971) 0.96
Locus coeruleus lesions decrease norepinephrine input into the medial preoptic area and medial basal hypothalamus and block the LH, FSH and prolactin preovulatory surge. Brain Res (1997) 0.95
Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins. Br J Pharmacol (1992) 0.95
Differential effects of pharmacological manipulations of central alpha 1- and alpha 2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology (1982) 0.95
Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat. Endocrinology (1971) 0.94
Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors. Gastroenterology (1992) 0.94
Effects of estrogen on plasma and pituitary gonadotropins and prolactin, and on hypothalamic releasing and inhibiting factors. Neuroendocrinology (1972) 0.92
Effect of acute exposure to cold on the activity of the hypothalamic-pituitary-thyroid system. Endocrinology (1975) 0.92
Hypothalamic areas involved in prostaglandin (PG)-induced gonadotropin release. II: effect of PGE2 and PGF2alpha implants on follicle stimulating hormone release. Endocrinology (1977) 0.92
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium. Cell Death Differ (2006) 0.91
Tachykinins and reflexly evoked atropine-resistant motility in the guinea pig colon in vivo. J Pharmacol Exp Ther (1993) 0.91
Vasoactive intestinal polypeptide in brain synaptosomes. Lancet (1976) 0.91
Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of action of adrenergic neurone blocking agents. Br J Pharmacol (1976) 0.91
Tachykinin receptors and intestinal motility. Can J Physiol Pharmacol (1997) 0.89
Acute and chronic responses to iodine deficiency in rats. Endocrinology (1977) 0.89
Acute and chronic effects of hypothalamic lesions on the release of FSH, LH and prolactin in intact and castrated rats. Endocrinology (1972) 0.89
Receptor binding profile of Otilonium bromide. Pharmacol Res (1998) 0.89
The use of optical flow to characterize muscle contraction. J Neurosci Methods (2001) 0.89
Further studies on the response of the guinea-pig isolated bronchus to endothelins and sarafotoxin S6b. Eur J Pharmacol (1990) 0.89
Subsensitivity of cardiac beta-adrenoceptors in renal hypertensive rats. J Cardiovasc Pharmacol (1980) 0.88
Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.88
Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum. Br J Pharmacol (1995) 0.88
Tachykinin receptors in the circular muscle of the guinea-pig ileum. Br J Pharmacol (1990) 0.86
NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype. Eur J Pharmacol (1991) 0.86
Exogenous BH4/Bcl-2 peptide reverts coronary endothelial cell apoptosis induced by oxidative stress. J Vasc Res (2004) 0.86
Motor response of the human isolated colon to capsaicin and its relationship to release of vasoactive intestinal polypeptide. Neuroscience (1990) 0.86
MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist. Br J Pharmacol (1998) 0.86
The possible role of ATP and PACAP as mediators of apaminsensitive NANC inhibitory junction potentials in circular muscle of guinea-pig colon. Br J Pharmacol (1996) 0.86
The onset of puberty in the female rat: changes in plasma prolactin, gonadotropins, luteinizing hormone-releasing hormone (LHRH), and hypothalamic LHRH content. Endocrinology (1976) 0.86
Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat. J Cardiovasc Pharmacol (2000) 0.85
NK-2 receptor agonists and antagonists. Ann N Y Acad Sci (1991) 0.85
Multiple sources of calcium for contraction of the human urinary bladder muscle. Br J Pharmacol (1989) 0.85
On the physiological disposition and possible mechanism of the antihypertensive action of debrisoquin. Biochem Pharmacol (1969) 0.85
Effect of endothelin-1, endothelin-3 and C-terminal hexapeptide, endothelin (16-21) on motor activity in rats. Neuropeptides (1990) 0.85
Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors. J Cardiovasc Pharmacol (1992) 0.84
The effect of catecholamines on hormone release from anterior pituitaries and ventral hypothalami incubated in vitro. Neuroendocrinology (1974) 0.84
Central neurotransmitters and the secretion of prolactin, GH, LH and TSH. Annu Rev Physiol (1979) 0.84
The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors. J Urol (1990) 0.83
The effect of a serotonin uptake inhibitor (Lilly 110140) on the sercretion of prolactin in the rat. Life Sci (1975) 0.83
Puberty delay of bank vole females in a high-density population. Biol Reprod (1986) 0.83
Muscarinic M1 receptors stimulate a nonadrenergic noncholinergic inhibitory pathway in the isolated rat duodenum. J Pharmacol Exp Ther (1988) 0.83
Direct evidence for the involvement of vasoactive intestinal polypeptide in the motor response of the human isolated ileum to capsaicin. Eur J Pharmacol (1990) 0.83
Changes in serum prolactin and gonadotropins during sexual development of the male rat. Endocrinology (1973) 0.83
On the prolactin-inhibiting effect of neurotensin. The role of dopamine. Neuroendocrinology (1982) 0.82
Influence of growth hormone (GH) on content of GH in the pituitaries of normal rats. Proc Soc Exp Biol Med (1966) 0.82
The effect of MK-801 on the micturition reflex in anesthetized rats. Eur J Pharmacol (1990) 0.82
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity. Oncogene (2011) 0.82
Modulation by stereoselective inhibition of cyclo-oxygenase of electromechanical coupling in the guinea-pig isolated renal pelvis. Br J Pharmacol (1995) 0.82
On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor. Endocrinology (1985) 0.81
The functional state of sympathetic nerves in spontaneously diabetic mice. Diabetes (1978) 0.81
Hypothalamic areas involved in prostaglandin (PG)-induced gonadotropin release. I: effects of PGE2 and PGF2alpha implants on luteinizing hormone release. Endocrinology (1977) 0.81
Effect of the host hormonal status on development of sucrase and acid beta-galactosidase in isografts of rat small intestine. J Endocrinol (1977) 0.81
Atropine inhibits thromboxane A2 generation in isolated lungs of the guinea-pig. Br J Pharmacol (1980) 0.81
A renin-like activity in the human hypophysis. Endocrinologie (1977) 0.81
An integrated simulator for surgery of the petrous bone. Stud Health Technol Inform (2001) 0.81
Localization and binding of reserpine in the membrane of adrenomedullary amine storage granules. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.81
The effects of gonadal steroids on plasma gonadotropins and prolactin in the rat. Endocrinology (1973) 0.81
Pharmacokinetics and pharmacodynamics of idrapril in rats, dogs, and humans. Drug Metab Dispos (1993) 0.81
The reserpine receptor. Life Sci (1978) 0.81
In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist. Eur J Pharmacol (1990) 0.80
Vasoactive intestinal polypeptide (VIP) stimulates adenylate cyclase in selected areas of rat brain. Life Sci (1979) 0.80
Effects of nucleus basolateralis amygdalae neurotoxic lesions on aversive conditioning in the rat. Physiol Behav (1991) 0.80
Role of muscarinic receptor subtypes in the regulation of migrating myoelectric complex in the dog. Gastroenterology (1989) 0.80
Evidence for the presence of growth hormone-releasing factor in blood of hyperglycemic, hypophysectomized rats. Proc Soc Exp Biol Med (1966) 0.80
Optical specificity of monoamine oxidase. Life Sci (1966) 0.80
Pregnancy block elicited by urinary proteins of male mice. Biol Reprod (1977) 0.80
Facilitation of reflex micturition by intravesical administration of [beta Ala8]-neurokinin A (4-10), a selective NK-2 tachykinin receptor agonist. J Urol (1991) 0.80
Dual actions of guanethidine on amine uptake mechanisms in adrenergic neurons. Biochem Pharmacol (1966) 0.80
Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine. Neuroendocrinology (1986) 0.80
The effects of neurotensin on anterior pituitary hormone secretion. Ann N Y Acad Sci (1982) 0.80
The effect of colchicine on the release of rat anterior pituitary hormones in vitro. Proc Soc Exp Biol Med (1973) 0.79